Cargando…

Prospective surveillance of women with a family history of breast cancer: auditing the risk threshold

To evaluate current guidelines criteria for inclusion of women in special ‘breast cancer family history’ surveillance programmes, records were reviewed of women referred to Scottish breast cancer family clinics between January 1994 and December 2003 but discharged as at ‘less than ‘moderate’ familia...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, E, Berg, J, Black, R, Bradshaw, N, Campbell, J, Carnaghan, H, Cetnarkyj, R, Drummond, S, Davidson, R, Dunlop, J, Fordyce, A, Gibbons, B, Goudie, D, Gregory, H, Holloway, S, Longmuir, M, McLeish, L, Murday, V, Miedzybrodska, Z, Nicholson, D, Pearson, P, Porteous, M, Reis, M, Slater, S, Smith, K, Smyth, E, Snadden, L, Steel, M, Stirling, D, Watt, C, Whyte, C, Young, D
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259176/
https://www.ncbi.nlm.nih.gov/pubmed/18283300
http://dx.doi.org/10.1038/sj.bjc.6604155
_version_ 1782151358864949248
author Anderson, E
Berg, J
Black, R
Bradshaw, N
Campbell, J
Carnaghan, H
Cetnarkyj, R
Drummond, S
Davidson, R
Dunlop, J
Fordyce, A
Gibbons, B
Goudie, D
Gregory, H
Holloway, S
Longmuir, M
McLeish, L
Murday, V
Miedzybrodska, Z
Nicholson, D
Pearson, P
Porteous, M
Reis, M
Slater, S
Smith, K
Smyth, E
Snadden, L
Steel, M
Stirling, D
Watt, C
Whyte, C
Young, D
author_facet Anderson, E
Berg, J
Black, R
Bradshaw, N
Campbell, J
Carnaghan, H
Cetnarkyj, R
Drummond, S
Davidson, R
Dunlop, J
Fordyce, A
Gibbons, B
Goudie, D
Gregory, H
Holloway, S
Longmuir, M
McLeish, L
Murday, V
Miedzybrodska, Z
Nicholson, D
Pearson, P
Porteous, M
Reis, M
Slater, S
Smith, K
Smyth, E
Snadden, L
Steel, M
Stirling, D
Watt, C
Whyte, C
Young, D
author_sort Anderson, E
collection PubMed
description To evaluate current guidelines criteria for inclusion of women in special ‘breast cancer family history’ surveillance programmes, records were reviewed of women referred to Scottish breast cancer family clinics between January 1994 and December 2003 but discharged as at ‘less than ‘moderate’ familial risk’. The Scottish Cancer Registry was then interrogated to determine subsequent age-specific incidence of breast cancer in this cohort and corresponding Scottish population figures. Among 2074 women, with an average follow-up of 4.0 years, 28 invasive breast cancers were recorded up to December 2003, where 14.4 were expected, a relative risk (RR) of 1.94. Eleven further breast cancers were recorded between January 2004 and February 2006 (ascertainment incomplete for this period). The overall RR for women in the study cohort exceeded the accepted ‘cutoff’ level (RR=1.7) for provision of special counselling and surveillance. The highest RR was found for the age group 45–59 years and this group also generated the majority of breast cancers. The National Institute for Clinical Excellence (‘NICE’) guidelines appear to be more accurate than those of the Scottish Intercollegiate Guidelines Network (‘SIGN’) in defining ‘moderate’ familial risk, and longer follow-up of this cohort could generate an evidence base for further modification of familial breast cancer services.
format Text
id pubmed-2259176
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-22591762009-09-10 Prospective surveillance of women with a family history of breast cancer: auditing the risk threshold Anderson, E Berg, J Black, R Bradshaw, N Campbell, J Carnaghan, H Cetnarkyj, R Drummond, S Davidson, R Dunlop, J Fordyce, A Gibbons, B Goudie, D Gregory, H Holloway, S Longmuir, M McLeish, L Murday, V Miedzybrodska, Z Nicholson, D Pearson, P Porteous, M Reis, M Slater, S Smith, K Smyth, E Snadden, L Steel, M Stirling, D Watt, C Whyte, C Young, D Br J Cancer Genetics and Genomics To evaluate current guidelines criteria for inclusion of women in special ‘breast cancer family history’ surveillance programmes, records were reviewed of women referred to Scottish breast cancer family clinics between January 1994 and December 2003 but discharged as at ‘less than ‘moderate’ familial risk’. The Scottish Cancer Registry was then interrogated to determine subsequent age-specific incidence of breast cancer in this cohort and corresponding Scottish population figures. Among 2074 women, with an average follow-up of 4.0 years, 28 invasive breast cancers were recorded up to December 2003, where 14.4 were expected, a relative risk (RR) of 1.94. Eleven further breast cancers were recorded between January 2004 and February 2006 (ascertainment incomplete for this period). The overall RR for women in the study cohort exceeded the accepted ‘cutoff’ level (RR=1.7) for provision of special counselling and surveillance. The highest RR was found for the age group 45–59 years and this group also generated the majority of breast cancers. The National Institute for Clinical Excellence (‘NICE’) guidelines appear to be more accurate than those of the Scottish Intercollegiate Guidelines Network (‘SIGN’) in defining ‘moderate’ familial risk, and longer follow-up of this cohort could generate an evidence base for further modification of familial breast cancer services. Nature Publishing Group 2008-02-26 2008-02-19 /pmc/articles/PMC2259176/ /pubmed/18283300 http://dx.doi.org/10.1038/sj.bjc.6604155 Text en Copyright © 2008 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Genetics and Genomics
Anderson, E
Berg, J
Black, R
Bradshaw, N
Campbell, J
Carnaghan, H
Cetnarkyj, R
Drummond, S
Davidson, R
Dunlop, J
Fordyce, A
Gibbons, B
Goudie, D
Gregory, H
Holloway, S
Longmuir, M
McLeish, L
Murday, V
Miedzybrodska, Z
Nicholson, D
Pearson, P
Porteous, M
Reis, M
Slater, S
Smith, K
Smyth, E
Snadden, L
Steel, M
Stirling, D
Watt, C
Whyte, C
Young, D
Prospective surveillance of women with a family history of breast cancer: auditing the risk threshold
title Prospective surveillance of women with a family history of breast cancer: auditing the risk threshold
title_full Prospective surveillance of women with a family history of breast cancer: auditing the risk threshold
title_fullStr Prospective surveillance of women with a family history of breast cancer: auditing the risk threshold
title_full_unstemmed Prospective surveillance of women with a family history of breast cancer: auditing the risk threshold
title_short Prospective surveillance of women with a family history of breast cancer: auditing the risk threshold
title_sort prospective surveillance of women with a family history of breast cancer: auditing the risk threshold
topic Genetics and Genomics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259176/
https://www.ncbi.nlm.nih.gov/pubmed/18283300
http://dx.doi.org/10.1038/sj.bjc.6604155
work_keys_str_mv AT andersone prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT bergj prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT blackr prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT bradshawn prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT campbellj prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT carnaghanh prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT cetnarkyjr prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT drummonds prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT davidsonr prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT dunlopj prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT fordycea prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT gibbonsb prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT goudied prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT gregoryh prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT holloways prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT longmuirm prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT mcleishl prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT murdayv prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT miedzybrodskaz prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT nicholsond prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT pearsonp prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT porteousm prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT reism prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT slaters prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT smithk prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT smythe prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT snaddenl prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT steelm prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT stirlingd prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT wattc prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT whytec prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold
AT youngd prospectivesurveillanceofwomenwithafamilyhistoryofbreastcancerauditingtheriskthreshold